Clinical Trial Update: Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

View source ↗

Summary

The clinical trial assessing precision performance status in breast cancer patients receiving neoadjuvant chemotherapy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Status: TERMINATED